One major issue is the broad expression of TAM receptors (Tyro3, Axl, MerTK) across both tumor and normal tissues, which increases the risk of off-tumor effects such as impaired clearance of apoptotic cells and autoimmune-like toxicities. The gene discussed is AXL; the disease is neoplasm.